Rituxan (rituximab) - Roche
cyclophosphamide - Generic mfg.
prednisone - Generic mfg.
An Uncommon Presentation of ANCA-Associated Vasculitis: Gallbladder Involvement with Rapid Progressive Glomerulonephritis (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0760; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Treatment included pulse dose steroids, followed by a prednisone taper, five sessions of plasmapheresis, two dose of intrravenous cyclophosphamide and rituximab 1000 mg for two doses. Gallbladder involvement is even rarer with literature confined to case reports. Further studies examining the prevalence and associated factors would help characterize this population and potentially avoid unneeded surgeries." 
Acute Kidney Injury • ANCA Vasculitis • Asthma • Cardiovascular • Gastroenterology • Gastrointestinal Disorder • Glomerulonephritis • Hematological Disorders • Hepatology • Hypertension • Immunology • Inflammation • Inflammatory Bowel Disease • Lupus Nephritis • Nephrology • Renal Disease • Respiratory Diseases • Thrombosis • Vasculitis
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4546730
 
Joshua G. Wiesner; Omar Gutierrez; Madeline S. Chung
 
Oct 2, 2026
 
Prev Next